222
THE ENZYME TREATMENT OF
CANCER
as
now recognized by me, as a rule not free from exceptions—they were not in
former years strong enough for their work. In various quarters of the world
worthless preparations of trypsin and amylopsin have been offered for sale, at
times extensively advertised, and employed in cases of cancer, to the serious
detriment of the scientific enzyme treatment of cancer. The problem is—and it
is not one for the scientific investigator as such— How shall this sort of
happening be prevented in the future? It is an extremely grave matter, for
human lives are at stake in this treatment. One of the chief medical newspapers
in Great Britain, the Lancet, has as one of its features—and a most
excellent one it is—a laboratory for the making of scientific examinations and
the drawing up and publication of reports upon pharmaceutical products offered
for sale and for use in medicine. To my knowledge, none of the injections
employed hitherto in the treatment of cancer have been reported upon by this
laboratory, and in default of State control and State monopoly the sooner and
the oftener such examination and report upon various pancreatic preparations be
made the better for mankind and for science.